Your Source for Venture Capital and Private Equity Financings

Hemanext Closes $18M Series B

2022-11-07
LEXINGTON, MA, Hemanext, a leading innovator in blood processing, storage, and transfusion technology, announced the successful first close of its Series B fundraising round.
Hemanext, a leading innovator in blood processing, storage, and transfusion technology, announced the successful first close of its Series B fundraising round. Taken together with the exercise of outstanding warrants, this close brings an additional $18 million of equity capital from noted global private investors with deep finance and healthcare expertise. To date, the company has raised approximately $130mm.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors